Anti-TNF Agents in Behçet's Disease Treatment

Semih Tatlıcan

Issue: Volume 24 - Issue 1 - June 2009
1273 3101

A Case with Anti TNF- α Induced Bullous Pemhigoid

Özlem Altındağ, Ali Aydeniz, Savaş Gürsoy

DOI: 10.5152/tjr.2010.31

Issue: Volume 25 - Issue 4 - December 2010
9134 6200

A Case with Familial Mediterranean Fever which Responds Well to Adalimumab Treatment

Özgür ORTANCIL, Aslan SANLI, Perihan SAPMAZ BULMUŞ, Selda SARIKAYA

DOI: 10.5606/tjr.2011.024

Issue: Volume 26 - Issue 2 - June 2011
10211 5975

Anemia of Chronic Disease in Ankylosing Spondylitis: Improvement Following Anti-TNF Therapy

Ki-Jo KIM, Chul-Soo CHO

DOI: 10.5606/tjr.2012.014

Issue: Volume 27 - Issue 2 - June 2012
31678 6521

Association of Tumor Necrosis Factor-Alpha -308 G>A Polymorphism With Rheumatoid Arthritis in Two North Indian Cohorts

Priyanka RAINA, Kawaljit MATHAROO, Ajay KUMAR, Priyanka SARANGAL, Rubina SHARMA, AJS BHANWER

DOI: 10.5606/ArchRheumatol.2014.4499

Issue: Volume 29 - Issue 4 - December 2014
8109 4775

Arterial Stiffness and Anti-Tumor Necrosis Factor-Alpha Therapy in Ankylosing Spondylitis: Results With Long-Term Two Year-Follow-Up

Murat KARKUCAK, Erhan ÇAPKIN, Abdulkadir KİRİŞ, Mürsel ŞAHİN, Ayşegül KÜÇÜKALİ TÜRKYILMAZ, Adem KARACA, Ferhat GÖKMEN, Ahmet AYAR

DOI: 10.5606/ArchRheumatol.2014.4261

Issue: Volume 29 - Issue 4 - December 2014
6858 4956

Efficacy of Tumor Necrosis Factor Inhibitors in Patients With Ankylosing Spondylitis

Deniz DÜLGEROĞLU ERDOĞDU, Ajda BAL, Özgür KARAAHMET, Sibel ERKOÇ, Tuğba YALÇIN, Aytül ÇAKCI

DOI: 10.5606/ArchRheumatol.2014.4045

Issue: Volume 29 - Issue 4 - December 2014
9046 5207

Evaluation of Various Factors Leading to Osteolytic and Antiosteolytic Effects in Patients With Rheumatoid Arthritis

Kazım Serkan SUNAL, Ayşen CANİKLİOĞLU, Hüseyin DEMİR, Emre ERSOY, Derya KOÇER, Kıymet DOLBUN SEÇKİN, Aysun ŞAHİN SUNAL, Gülden BAŞKOL

DOI: 10.5606/ArchRheumatol.2015.4908

Issue: Volume 30 - Issue 1 - March 2015
7814 4465

Late Onset Prosthetic Hip Joint Infection in Two Patients of Rheumatoid Arthritis Treated With Etanercept

Hayashi SHINYA, Sakai YOSHITADA, Fujishiro TAKAAKI, Hashimoto SHINGO, Kanzaki NORIYUKI, Kuroda RYOSUKE, Kurosaka MASAHIRO

DOI: 10.5606/ArchRheumatol.2015.4528

Issue: Volume 30 - Issue 2 - June 2015
5750 4648

Comparison of Glucocorticoid and Nonsteroidal Anti-Inflammatory Drug Requirement Before and After Tumor Necrosis Factor Inhibitor Treatment in Patients With Rheumatoid Arthritis

Merih BİRLİK, Sedat ÇAPAR, Servet AKAR, İsmail SARI, Fatos ÖNEN, Nurullah AKKOÇ

DOI: 10.5606/ArchRheumatol.2015.5504

Issue: Volume 30 - Issue 3 - September 2015
9173 5080

Spinal Cord Compression: An Infrequent Complication of SAPHO Syndrome

Sonia REKİK, Maroua SLOUMA, Hela SAHLİ, Elhem CHEOUR, Mohamed ELLEUCH

DOI: 10.5606/ArchRheumatol.2015.5571

Issue: Volume 30 - Issue 3 - September 2015
6721 5238

Monocyte Expression Levels of Cytokines in Patients With Fibromyalgia Syndrome

Evrim ÖĞÜT, Ali GÜR, Burhan Fatih KOÇYİĞİT, Serdar ÖZTUZCU, Beyhan CENGİZ, Özlem ALTINDAĞ, Hilal KARAGÜLLÜ, Savaş GÜRSOY

DOI: 10.5606/ArchRheumatol.2015.5474

Issue: Volume 30 - Issue 4 - December 2015
6925 4832

Acute Lymphoid Leukemia After Anti-TNF-alpha Treatment: A Case Report and Review of the Literature

Füsun GEDİZ ÖZDEMİRKIRAN, Bahriye Kadriye PAYZIN, Eyüp ÇOBAN, Korhan Barış BAYRAM, Betül KÜÇÜKZEYBEK

DOI: 10.5606/ArchRheumatol.2015.5669

Issue: Volume 30 - Issue 4 - December 2015
7240 5977

Early Onset of Periodic Fever Syndrome in a Patient Carrying Both Tumor Necrosis Factor Receptor Superfamily 1A and Mediterranean Fever Mutations

Barbara KRASZEWSKA-GŁOMBA, Zofia SZYMAŃSKA-TOCZEK, Leszek SZENBORN

DOI: 10.5606/ArchRheumatol.2016.5802

Issue: Volume 31 - Issue 3 - September 2016
5100 5015

Tumor Necrosis Factor Alpha Gene Polymorphism and Association With Its Serum Level in Iranian Population with Rheumatoid Arthritis

Hossein HADINEDOUSHAN, Parisa NOORBAKHSH, Hossein SOLEYMANI-SALEHABADI

DOI: 10.5606/ArchRheumatol.2016.5907

Issue: Volume 31 - Issue 4 - December 2016
8714 5767

A Rare Adverse Effect of Anti-Tumor Necrosis Factor Alpha Therapy: Sarcoidosis

Gönen MENGİ, Feride GÖĞÜŞ

DOI: 10.5606/ArchRheumatol.2017.6055

Issue: Volume 32 - Issue 1 - March 2017
7638 5014

The Effect of Anti-Tumor Necrosis Factor-Alpha Treatment on Muscle Performance and Endurance in Patients With Ankylosing Spondylitis: A Prospective Follow-Up Study

Musa DEMİRKAPI, Mustafa Turgut YILDIZGÖREN, Hayal GÜLER, Ayşe Dicle TURHANOĞLU

DOI: 10.5606/ArchRheumatol.2017.6335

Issue: Volume 32 - Issue 4 - December 2017
4819 5730

Endocan Measurement for Active Behçet Disease

Ayhan KUL, Orhan ATEŞ, Meltem ALKAN MELİKOĞLU, Mahir UĞUR, Nurinnisa ÖZTÜRK, Gülsüm ERKAYHAN, İbrahim KOÇER

DOI: 10.5606/ArchRheumatol.2017.6072

Issue: Volume 32 - Issue 3 - September 2017
6022 5196

Tofacitinib Versus Non-Tumor Necrosis Factor Biologics for Patients With Active Rheumatoid Arthritis

Yukio NAKAMURA, Takako SUZUKI, Hideshi YAMAZAKI, Hiroyuki KATO

DOI: 10.5606/ArchRheumatol.2018.6366

Issue: Volume 33 - Issue 2 - June 2018
3642 4696

The Evaluation of Serum Tumor Necrosis Factor-Like Weak Inducer of Apoptosis, Interleukin-6, Fetuin-A, Homeostatic Model Assessment-Insulin Resistance, and Insulin Levels in Rheumatoid Arthritis Patients in Clinical Remission

Sinem SAĞ, Derya GÜZEL, Mustafa Serdar SAĞ, İbrahim TEKEOĞLU, Ayhan KAMANLI, Kemal NAS, Songül DOĞANAY

DOI: 10.5606/ArchRheumatol.2019.6722

Issue: Volume 34 - Issue 1 - March 2019
2386 2072